Format
Items per page
Sort by

Send to:

Choose Destination

Results: 12

PubMed Links for Books (Select 2407850)

1.

In vitro and in vivo characterization of novel 18F-labeled bombesin analogues for targeting GRPR-positive tumors.

Mu L, Honer M, Becaud J, Martic M, Schubiger PA, Ametamey SM, Stellfeld T, Graham K, Borkowski S, Lehmann L, Dinkelborg L, Srinivasan A.

Bioconjug Chem. 2010 Oct 20;21(10):1864-71. doi: 10.1021/bc100222u.

PMID:
20857927
2.

Direct one-step 18F-labeling of peptides via nucleophilic aromatic substitution.

Becaud J, Mu L, Karramkam M, Schubiger PA, Ametamey SM, Graham K, Stellfeld T, Lehmann L, Borkowski S, Berndorff D, Dinkelborg L, Srinivasan A, Smits R, Koksch B.

Bioconjug Chem. 2009 Dec;20(12):2254-61. doi: 10.1021/bc900240z.

PMID:
19921791
3.

Peptide receptor imaging of prostate cancer with radiolabelled bombesin analogues.

Schroeder RP, van Weerden WM, Bangma C, Krenning EP, de Jong M.

Methods. 2009 Jun;48(2):200-4. doi: 10.1016/j.ymeth.2009.04.002. Epub 2009 May 3. Review.

PMID:
19398012
4.

Gastrin-releasing peptide: different forms, different functions.

Ischia J, Patel O, Shulkes A, Baldwin GS.

Biofactors. 2009 Jan-Feb;35(1):69-75. doi: 10.1002/biof.10. Review.

PMID:
19319848
5.

Regulation and signaling of human bombesin receptors and their biological effects.

Weber HC.

Curr Opin Endocrinol Diabetes Obes. 2009 Feb;16(1):66-71. Review.

PMID:
19115523
6.

Nuclear imaging of prostate cancer with gastrin-releasing-peptide-receptor targeted radiopharmaceuticals.

Ananias HJ, de Jong IJ, Dierckx RA, van de Wiele C, Helfrich W, Elsinga PH.

Curr Pharm Des. 2008;14(28):3033-47. Review.

PMID:
18991717
7.

Synthesis, 18F-labeling, and in vitro and in vivo studies of bombesin peptides modified with silicon-based building blocks.

Höhne A, Mu L, Honer M, Schubiger PA, Ametamey SM, Graham K, Stellfeld T, Borkowski S, Berndorff D, Klar U, Voigtmann U, Cyr JE, Friebe M, Dinkelborg L, Srinivasan A.

Bioconjug Chem. 2008 Sep;19(9):1871-9. doi: 10.1021/bc800157h. Epub 2008 Aug 28.

PMID:
18754574
8.

Bombesin receptor antagonists may be preferable to agonists for tumor targeting.

Cescato R, Maina T, Nock B, Nikolopoulou A, Charalambidis D, Piccand V, Reubi JC.

J Nucl Med. 2008 Feb;49(2):318-26. doi: 10.2967/jnumed.107.045054. Epub 2008 Jan 16.

9.

18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer.

Zhang X, Cai W, Cao F, Schreibmann E, Wu Y, Wu JC, Xing L, Chen X.

J Nucl Med. 2006 Mar;47(3):492-501.

10.

Radiolabeled peptide conjugates for targeting of the bombesin receptor superfamily subtypes.

Smith CJ, Volkert WA, Hoffman TJ.

Nucl Med Biol. 2005 Oct;32(7):733-40. Review.

PMID:
16243649
11.

Potent bombesin-like peptides for GRP-receptor targeting of tumors with 99mTc: a preclinical study.

Nock BA, Nikolopoulou A, Galanis A, Cordopatis P, Waser B, Reubi JC, Maina T.

J Med Chem. 2005 Jan 13;48(1):100-10.

PMID:
15634004
12.

Gastrin releasing peptide (GRP) receptor targeted radiopharmaceuticals: a concise update.

Smith CJ, Volkert WA, Hoffman TJ.

Nucl Med Biol. 2003 Nov;30(8):861-8. Review.

PMID:
14698790
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk